The CAMAROS trial is a multicentre, randomized, double-blinded, controlled phase II trial analyzing the effect of coupling a C-C chemokine receptor 5 (CCR5) antagonist, Maraviroc (Celsentri), and exercise to improve both upper and lower extremity recovery after a stroke.
CAMAROS is a custom designed Electronic Data Capture (EDC), Randomization and Drug Management Solution developed for the purpose of facilitating the data collection for the CAMAROS Trial, while providing the following functions:
Want to know more about DCTMS? Please visit our DCTMS Product page or contact us for a free demo!
Our main areas of expertise are in the Healthcare, Academic, Education as well as the Energy Sector, where we provide solutions for a number of needs: